Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial

Yi Xia; Li Wang; Kaiyang Ding; Jiazhu Wu; Hua Yin; Maogui Hu; Haorui Shen; Jinhua Liang; Ruize Chen; Yue Li; Huayuan Zhu; Jianyong Li; Wei Xu

doi:10.1097/CM9.0000000000002636

Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial

Chin Med J (Engl). 2023 Jun 20;136(12):1491-1493. doi: 10.1097/CM9.0000000000002636. Epub 2023 Apr 7.

Authors

Yi Xia^{1

2

3}, Li Wang^{1

2

3}, Kaiyang Ding⁴, Jiazhu Wu^{1

2

3}, Hua Yin^{1

2

3}, Maogui Hu⁴, Haorui Shen^{1

2

3}, Jinhua Liang^{1

2

3}, Ruize Chen^{1

2

3}, Yue Li^{1

2

3}, Huayuan Zhu^{1

2

3}, Jianyong Li^{1

2

3

5}, Wei Xu^{1

2

3}

Affiliations

¹ Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, China.
² Key Laboratory of Hematology of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
³ Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, Jiangsu 210029, China.
⁴ Department of Hematology, The First Affiliated Hospital of USTC Anhui Provincial Hospital, Hefei, Anhui 230001, China.
⁵ National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, China.

No abstract available

Publication types

Clinical Trial, Phase II

MeSH terms

Aminopyridines / therapeutic use
Antineoplastic Combined Chemotherapy Protocols
Hematopoietic Stem Cell Transplantation*
Humans
Lymphoma, Non-Hodgkin* / drug therapy
Transplantation, Autologous

Substances

N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
Aminopyridines